logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Amesimeku, Theophilus
    Pharmacist born in June 1974
    Individual (20 offsprings)
    Officer
    icon of calendar 2022-11-14 ~ now
    OF - Director → CIF 0
    Mr Theophilus Amesimeku
    Born in June 1974
    Individual (20 offsprings)
    Person with significant control
    icon of calendar 2022-11-14 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

CLARKE PHARMACY LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Par Value of Share
Class 1 ordinary share
12023-12-01 ~ 2024-11-30
Intangible Assets
682,500 GBP2024-11-30
760,500 GBP2023-11-30
Property, Plant & Equipment
13,498 GBP2024-11-30
17,098 GBP2023-11-30
Fixed Assets
695,998 GBP2024-11-30
777,598 GBP2023-11-30
Total Inventories
40,200 GBP2024-11-30
18,650 GBP2023-11-30
Debtors
241,593 GBP2024-11-30
38,797 GBP2023-11-30
Cash at bank and in hand
30,304 GBP2024-11-30
52,193 GBP2023-11-30
Current Assets
312,097 GBP2024-11-30
109,640 GBP2023-11-30
Net Current Assets/Liabilities
-233,836 GBP2024-11-30
-208,688 GBP2023-11-30
Total Assets Less Current Liabilities
462,162 GBP2024-11-30
568,910 GBP2023-11-30
Creditors
Non-current
-600,120 GBP2024-11-30
-601,856 GBP2023-11-30
Net Assets/Liabilities
-137,958 GBP2024-11-30
-32,946 GBP2023-11-30
Equity
Called up share capital
100 GBP2024-11-30
100 GBP2023-11-30
Retained earnings (accumulated losses)
-138,058 GBP2024-11-30
-33,046 GBP2023-11-30
Equity
-137,958 GBP2024-11-30
-32,946 GBP2023-11-30
Average Number of Employees
22023-12-01 ~ 2024-11-30
22022-11-14 ~ 2023-11-30
Intangible Assets - Gross Cost
Net goodwill
780,000 GBP2023-11-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
97,500 GBP2024-11-30
19,500 GBP2023-11-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
78,000 GBP2023-12-01 ~ 2024-11-30
Intangible Assets
Net goodwill
682,500 GBP2024-11-30
760,500 GBP2023-11-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
17,998 GBP2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
4,500 GBP2024-11-30
900 GBP2023-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
3,600 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment
Plant and equipment
13,498 GBP2024-11-30
17,098 GBP2023-11-30
Trade Debtors/Trade Receivables
Current
33,780 GBP2024-11-30
11,950 GBP2023-11-30
Amount of value-added tax that is recoverable
Current
12,423 GBP2024-11-30
13,562 GBP2023-11-30
Prepayments
Current
11,049 GBP2024-11-30
10,661 GBP2023-11-30
Debtors
Amounts falling due within one year, Current
241,593 GBP2024-11-30
38,797 GBP2023-11-30
Bank Borrowings/Overdrafts
Current
24,824 GBP2023-11-30
Trade Creditors/Trade Payables
Current
66,626 GBP2024-11-30
65,774 GBP2023-11-30
Accrued Liabilities
Current
900 GBP2024-11-30
900 GBP2023-11-30
Bank Borrowings/Overdrafts
Between two and five year, Non-current
600,120 GBP2024-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-11-30
Profit/Loss
Retained earnings (accumulated losses)
-105,012 GBP2023-12-01 ~ 2024-11-30

  • CLARKE PHARMACY LIMITED
    Info
    Registered number 14482746
    icon of address1053 London Road, Leigh-on-sea, Essex SS9 3JP
    Private Limited Company incorporated on 2022-11-14 (2 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.